4-(tert-Butoxycarbonylamino)cyclohexanone>98.0%(GC)5g

Cyclohexylthiourea>98.0%(HPLC)(N)200mg

(S)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid, 95.0%, 1g

rel-4-Bromo-N1-((1r,4r)-4-methoxycyclohexyl)benzene-1,2-diamine, 98%, 250mg

[1-(2-methoxyethyl)pyrrolidin-3-yl]methanol, 95.0%, 10g

Piperidin-4-yl-pyrimidin-2-yl-amine hydrochloride, 95.0%, 5g

Benzyl phenyl sulfide, 99.0%, 10g

METHYL 5-(HYDROXYMETHYL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLATE, 95.0%, 250mg

Methyl 3-[(1R*,4R*)-4-(tert-butoxycarbonylamino)-cyclohexylamino]methyl]benzoate, 1g

Bilancia analitica e di precisione serie Entris® II Modelli con regolazione interna, calibrata in fabbrica, 0,0001 g, 60 g, BCE64i-1S (W)

7-Chloroisatin, 97.0%, 25g

Ganci da parete SEKUROKA®, per protezione facciale, 1 pezzo

(2-Methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)methanol, 97%, 250mg